This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NYSE, Primerica: New Targets, Estimates

Also see: Nokia, LinkedIn: Analysts' New Ratings

NEW YORK ( TheStreet) -- STOCK COMMENTS/EPS CHANGES

Air Products (APD - Get Report) numbers were raised at Morgan Stanley. Shares now seen reaching $115. Estimates also increased, given better end-market demand, Morgan Stanley said. Overweight rating.

Dow Chemical (DOW - Get Report) estimates were lowered through 2012 at UBS. Lower pricing could hurt near-term margins, UBS said. Buy rating and $46.50 price target.

WR Grace (GRA - Get Report) estimates were increased through 2012 at Jefferies. Company has multiple potential growth drivers, Jefferies said. Buy rating and $56 price target.

Nasdaq (NDAQ) estimates, target were reduced at Barclays. Shares now seen reaching $32. Estimates also cut, as trading volume has declined, Barclays said. Overweight rating.

NYSE Euronext (NYX) numbers were cut at Barclays. Shares now seen reaching $41. Estimates also lowered, given lower trading volume in Europe, Barclays said. Overweight rating.

Primerica (PRI - Get Report) estimates, target were reduced at UBS. Shares of PRI now seen reaching $22. Estimates also cut, given weaker equity markets and slower economic growth, UBS said. Neutral rating.

RadioShack (RSH) estimates, target were lowered through 2012 at Barclays Capital. The company continues to face cost headwinds, Barclays said. Underweight rating and new $12 price target.

Seattle Genetics (SGEN - Get Report) numbers were boosted at ThinkEquity. Shares are now seen reaching $26. Estimates also upped, given better expected pricing for Adcetris, according to ThinkEquity. Buy rating.

End of report.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
NYX $0.00 0.00%
RSH $0.31 12.76%
APD $146.60 0.00%
DOW $51.69 0.00%
GRA $97.33 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs